Related Experiment Video

Updated: May 31, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas

Jin Zhang1, Seong-Jun Cho, Limin Shu

  • 1Comparative Cancer Center, Schools of Medicine and Veterinary Medicine, University of California at Davis, USA.

Genes & Development
|July 19, 2011
PubMed

Insights

The RNA-binding protein RNPC1 regulates p53 translation, a key tumor suppressor. RNPC1 overexpression inhibits p53, potentially contributing to cancer by repressing this vital pathway.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The p53 pathway is a crucial tumor suppressor mechanism.
  • Dysregulation of p53 is implicated in the majority of human cancers.
  • Understanding p53 regulation is vital for cancer therapy development.

Purpose of the Study:

  • To identify novel regulators of p53 translation.
  • To elucidate the role of RNA-binding protein 1 (RNPC1) in p53 regulation.
  • To investigate the potential involvement of RNPC1 in tumorigenesis.

Main Methods:

  • Investigated RNPC1's effect on p53 translation using ectopic expression and knockdown.
  • Utilized co-immunoprecipitation and RNA-binding assays to determine interaction mechanisms.
  • Examined p53 protein levels and senescence in RNPC1-deficient mouse embryonic fibroblasts.
  • Analyzed RNPC1 and p53 expression in canine lymphoma samples.

Main Results:

  • RNPC1 acts as a negative regulator of p53 translation.
  • RNPC1 physically interacts with eIF4E and binds p53 mRNA's 5' and 3' UTRs.
  • Loss of RNPC1 leads to increased p53 protein levels and p53-dependent premature senescence.
  • RNPC1 is overexpressed in canine lymphomas, correlating with decreased wild-type p53.

Conclusions:

  • A novel p53-RNPC1 autoregulatory loop exists, where RNPC1 represses p53 translation.
  • RNPC1's repression of p53 suggests a role in tumorigenesis.
  • RNPC1 may represent a therapeutic target in cancers with wild-type p53.

More Related Videos

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...